Dr. Lal PathLabs Limited (LALPATHLAB.BO)
INR 3018.95
(-0.63%)
INR 3018.95
(-0.63%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.71 Billion | 4.56 Billion | 4.46 Billion | 3.98 Billion | 2.83 Billion | 2.18 Billion |
| Net Income | 3.57 Billion | 2.41 Billion | 3.5 Billion | 2.96 Billion | 2.27 Billion | 2 Billion |
| Depreciation & Amortization | 1.43 Billion | 1.5 Billion | 1.08 Billion | 771.98 Million | 728.1 Million | 382.2 Million |
| Deferred income taxes | - | 25 Million | -103 Million | -42.4 Million | -153.85 Million | -108.69 Million |
| Stock-based compensation | 217 Million | 226 Million | 323 Million | 203.74 Million | 166.37 Million | 150.46 Million |
| Change in working capital | 357 Million | 355 Million | -167 Million | 366.71 Million | 121.67 Million | 93.04 Million |
| Other non-cash items | 3.01 Billion | 39 Million | -170 Million | -283.32 Million | -299.26 Million | -336.31 Million |
| Investing Cash Flow | -696 Million | -2.87 Billion | -4.49 Billion | -2.12 Billion | -261.12 Million | -997.37 Million |
| Investments in PPE | -575 Million | -446 Million | -4.76 Billion | -595.9 Million | -796.15 Million | -420.38 Million |
| Acquisitions | 5 Million | -178 Million | -4.57 Billion | -31.5 Million | -277.59 Million | -8.14 Million |
| Investment purchases | -9.81 Billion | -11.34 Billion | -8.47 Billion | -12.58 Billion | -11.02 Billion | -6.11 Billion |
| Sales/Maturities of investments | 9.69 Billion | 8.78 Billion | 12.8 Billion | 10.68 Billion | 11.42 Billion | 5.27 Billion |
| Other Investing Activities | 20 Million | 311 Million | 512 Million | 400.34 Million | 414.92 Million | 272.13 Million |
| Financing Cash Flow | -4.04 Billion | -2.83 Billion | 1.36 Billion | -1.38 Billion | -1.9 Billion | -552.61 Million |
| Debt repayment | -1.53 Billion | -1.09 Billion | -3.45 Billion | -392.2 Million | - | -2.16 Million |
| Dividends payments | -2.01 Billion | -1.03 Billion | -1.16 Billion | -994.83 Million | -1.55 Billion | -551.9 Million |
| Common Stock Repurchased | - | -720 Million | 6.9 Billion | -10 Thousand | - | -30 Thousand |
| Common Stock Issuance | 35 Million | 9 Million | 2 Million | 1.49 Million | 1.66 Million | 1.51 Million |
| Other Financing Activities | -628.45 Million | -1 Million | -925.23 Million | -10 Thousand | -351.09 Million | -30 Thousand |
| Accounts receivables | -72 Million | 30.9 Million | -181.72 Million | -205.08 Million | -40.73 Million | -185.1 Million |
| Accounts payables | 305 Million | 92.27 Million | 34.33 Million | 269.2 Million | 380.74 Million | 146.53 Million |
| Inventory | -35 Million | 187 Million | -100 Million | 144.02 Million | -284.25 Million | -12 Million |
| Other working capital | 159 Million | 44.83 Million | 80.39 Million | 158.57 Million | 65.91 Million | 143.61 Million |
| Cash at beginning of period | 2.64 Billion | 3.78 Billion | 2.44 Billion | 1.96 Billion | 1.29 Billion | 658.48 Million |
| Cash at end of period | 8.3 Billion | 2.63 Billion | 3.78 Billion | 2.44 Billion | 1.96 Billion | 1.29 Billion |
| Capital Expenditure | -575 Million | -446 Million | -4.76 Billion | -595.9 Million | -796.15 Million | -420.38 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.65 Billion | -1.14 Billion | 1.33 Billion | 475.78 Million | 673.33 Million | 635.39 Million |
| Free Cash Flow | 5.13 Billion | 4.11 Billion | -294 Million | 3.38 Billion | 2.04 Billion | 1.76 Billion |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.57 Billion | 813 Million | 1.09 Billion | 826 Million | 2.41 Billion | 567 Million |
| Depreciation & Amortization | 1.43 Billion | 360 Million | 359 Million | 351 Million | 1.5 Billion | 376 Million |
| Deferred income taxes | - | - | - | - | 25 Million | - |
| Stock-based compensation | 217 Million | - | - | - | 226 Million | - |
| Change in working capital | 357 Million | - | - | - | 355 Million | - |
| Other non-cash items | 3.01 Billion | -360 Million | -359 Million | -351 Million | 39 Million | -376 Million |
| Investing Cash Flow | -696 Million | - | - | - | -2.87 Billion | - |
| Investments in PPE | -575 Million | - | - | - | -446 Million | - |
| Acquisitions | 5 Million | - | - | - | -178 Million | - |
| Investment purchases | -9.81 Billion | - | - | - | -11.34 Billion | - |
| Sales/Maturities of investments | 9.69 Billion | - | - | - | 8.78 Billion | - |
| Other Investing Activities | 20 Million | - | - | - | 311 Million | - |
| Financing Cash Flow | -4.04 Billion | - | - | - | -2.83 Billion | - |
| Debt repayment | -1.53 Billion | - | - | - | -1.09 Billion | - |
| Dividends payments | -2.01 Billion | - | - | - | -1.03 Billion | - |
| Common Stock Repurchased | - | - | - | - | -720 Million | - |
| Common Stock Issuance | 35 Million | - | - | - | 9 Million | - |
| Other Financing Activities | - | - | - | - | -1 Million | - |
| Accounts receivables | -72 Million | - | - | - | 30.9 Million | - |
| Accounts payables | 305 Million | - | - | - | 92.27 Million | - |
| Inventory | -35 Million | - | - | - | 187 Million | - |
| Other working capital | 159 Million | - | - | - | 44.83 Million | - |
| Cash at beginning of period | 2.64 Billion | 7.86 Billion | 6.77 Billion | 2.64 Billion | 3.78 Billion | 2.08 Billion |
| Cash at end of period | 8.3 Billion | 813 Million | 7.86 Billion | 826 Million | 2.63 Billion | 2.64 Billion |
| Capital Expenditure | -575 Million | - | - | - | -446 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.65 Billion | -7.05 Billion | 1.09 Billion | -1.82 Billion | -1.14 Billion | 567 Million |
| Free Cash Flow | 5.13 Billion | 813 Million | 1.09 Billion | 826 Million | 4.11 Billion | 567 Million |
SHMM
ALHGR
ELEMF
0096
CFL
000910